Related Experiment Video
Updated: Jun 4, 2026

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
Infantile muscular dystrophy in Canadian aboriginals is an αB-crystallinopathy
Marc R Del Bigio1, Albert E Chudley, Harvey B Sarnat
1Department of Pathology, University of Manitoba, Winnipeg, Canada.
Insights
A genetic mutation in the CRYAB gene causes fatal infantile hypertonic muscular dystrophy in Canadian aboriginal infants. This severe condition results from homozygosity for a hypomorphic allele, leading to myofibrillar myopathy.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- A rare, recessively inherited fatal infantile hypertonic muscular dystrophy affects Canadian aboriginal infants.
- Affected infants exhibit progressive muscle stiffness and severe respiratory insufficiency, often leading to death within the first year of life.
Purpose of the Study:
- To identify the genetic basis of this severe infantile muscular dystrophy.
Main Methods:
- Histochemical, immunocytochemical, electron microscopy, and molecular genetic analyses were performed on 12 patients.
- Mutation screening of the CRYAB gene was conducted in DNA samples from 8 patients.
Main Results:
- Studies suggested myofibrillar myopathy (MFM).
- Absence of alpha B-crystallin (αBC) expression was noted, with specific antibody staining revealing abnormalities.
- A homozygous deletion (c.60delC) in the CRYAB gene, leading to a premature stop codon (p.Ser21AlafsX24), was identified in all affected patients.
- Heterozygous carriers were identified in unaffected parents.
Conclusions:
- The homozygous c.60delC mutation in the CRYAB gene is the genetic cause of this fatal infantile hypertonic muscular dystrophy in Canadian aboriginals.
- Unlike typical dominant MFMs, this disease presents with recessive inheritance due to a hypomorphic allele.
- The severe phenotype in patients is attributed to homozygosity for this markedly hypomorphic allele, while limited expression rescues parental phenotype.
Objective:
A recessively transmitted fatal hypertonic infantile muscular dystrophy has been described in Canadian aboriginals. The affected infants present with progressive limb and axial muscle stiffness and develop severe respiratory insufficiency, and most die in the first year of life. We sought to determine the genetic basis of this disease.
Methods:
We performed histochemical, immunocytochemical, electron microscopy, and molecular genetic studies in a cohort of 12 patients affected by this disease.
Results:
Conventional histochemical and electron microscopy studies suggested myofibrillar myopathy (MFM). Therefore, we searched for ectopic expression of multiple proteins typical of MFM. Alpha B-crystallin (αBC) expression was absent from all fibers using a monoclonal antibody raised against the entire protein. However, a monoclonal antibody directed against the first 10 residues of αBC immunostained portions of abnormal fibers. Pursuing this clue, we searched for mutations in the gene for αBC (CRYAB) in available DNA samples of 8 patients. All harbored a homozygous deletion, c.60C, predicting a Ser to Ala change at codon 21 and a stop codon after 23 missense residues (p.Ser21AlafsX24). Clinically unaffected parents were heterozygous for this mutation.
Interpretation:
The homozygous c.60delC in CRYAB pinpoints the genetic basis of the fatal infantile hypertonic muscular dystrophy of Canadian aboriginals. MFMs are typically transmitted by dominant inheritance, but in this disease the parental phenotype is rescued by limited expression of the highly truncated nonfunctional mutant gene product. The severe patient phenotype is due to homozygosity for the markedly hypomorphic allele. Ann Neurol, 2011.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Sex-linked Disorders
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

